EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Rising Burden and Clinical Impact of Metabolic Syndrome in Inflammatory Bowel Disease: A Real‐World Cohort Study

Raseen Tariq iD, Kavin Parmar, Mahima Desai, Richard K Sterling, Arun J Sanyal

United European Gastroenterology Journal · 2026

DOI: 10.1002/ueg2.70255 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift United European Gastroenterology Journal, 2026. Verfasst von Raseen Tariq und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Metabolic Syndrome, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic syndrome (MetS) and its cardiometabolic complications are recognized in inflammatory bowel disease (IBD); however, longitudinal trends and their impact on outcomes remain incompletely defined. We aimed to evaluate temporal trends in cardiometabolic comorbidities and assess the impact of MetS on cardiometabolic, hepatic, renal, and IBD‐related outcomes.

Methods

We conducted a real‐world cohort study (2010–2024) including adults (≥ 18 years) with Crohn's disease or ulcerative colitis. Annual prevalence and incidence rates (per 1000 person‐years) of cardiometabolic comorbidities were calculated by the calendar year. Propensity score‐matched analyses compared outcomes among IBD with MetS, IBD alone, and MetS alone. Primary outcomes included major adverse cardiovascular events (MACE), heart failure, stroke, thromboembolism, chronic kidney disease (CKD), hepatic outcomes, all‐cause mortality, and IBD‐related events.

Results

Among adults with IBD, prevalence increased substantially from 2010–2011 to 2023–2024, including hypertension (12.7%–39.1%), obesity (3.6%–20.5%), diabetes (5.0%–16.0%), and MASLD/MASH (0.9%–8.7%), with parallel rises in incidence rates. Compared with MetS alone, IBD + MetS was associated with higher risks of MACE (adjusted hazard ratio [aHR] 1.19), CKD (1.27), MASLD/MASH (1.75), and cirrhosis (1.94). Compared with IBD alone, IBD + MetS conferred markedly higher risks of MACE (2.05), heart failure (2.17), CKD (2.07), and MASLD/MASH (2.36), as well as higher rates of hospitalization (1.48), corticosteroid use (1.43), and surgery (1.17). Mortality was higher in IBD + MetS than in IBD alone.

Discussion

Cardiometabolic comorbidities have risen sharply in IBD, and the coexistence of MetS substantially amplifies systemic and disease‐specific morbidity, supporting the need for integrated, metabolism‐informed IBD care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeInflammatory Bowel DiseasesCohort StudiesHumansAdultRetrospective StudiesCardiovascular DiseasesIncidencePrevalenceDiabetes Mellitus, Type 2ComorbidityMiddle AgedAged

Stichwörter der Autor:innen

Crohn's diseasecardiometabolic comorbiditiesinflammatory bowel diseasemetabolic dysfunction–associated steatotic liver diseasemetabolic syndromeobesityulcerative colitis

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, Virginia, USA.

ORCID-Profile: Raseen Tariq

Zitieren

APA

Tariq, R., Parmar, K., Desai, M., Sterling, R. K., & Sanyal, A. J. (2026). Rising Burden and Clinical Impact of Metabolic Syndrome in Inflammatory Bowel Disease: A Real‐World Cohort Study. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70255

Vancouver

Tariq R, Parmar K, Desai M, Sterling RK, Sanyal AJ. Rising Burden and Clinical Impact of Metabolic Syndrome in Inflammatory Bowel Disease: A Real‐World Cohort Study. United European Gastroenterology Journal. 2026. doi:10.1002/ueg2.70255

BibTeX
@article{Tariq2026,
  author = {Tariq, Raseen and Parmar, Kavin and Desai, Mahima and Sterling, Richard K and Sanyal, Arun J},
  title = {Rising Burden and Clinical Impact of Metabolic Syndrome in Inflammatory Bowel Disease: A Real‐World Cohort Study},
  journal = {United European Gastroenterology Journal},
  year = {2026},
  doi = {10.1002/ueg2.70255}
}
Kostenlos starten →